U.S. Top Stock Picks from Analysts

Autonomix Medical

Market Cap: US$7.4m

A development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.

Kiora Pharmaceuticals

Market Cap: US$7.3m

A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.

Sunshine Biopharma

Market Cap: US$7.1m

Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Brainstorm Cell Therapeutics

Market Cap: US$7.0m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

ENDRA Life Sciences

Market Cap: US$6.9m

Develops technologies to improve the capabilities of clinical diagnostic ultrasound.

BioCorRx

Market Cap: US$6.7m

Through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.

BiomX

Market Cap: US$6.7m

A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.

Lyra Therapeutics

Market Cap: US$6.5m

A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.

GRI Bio

Market Cap: US$6.5m

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.

Edible Garden

Market Cap: US$6.5m

Edible Garden AG Incorporated, together with its subsidiaries, operate as a controlled environment agriculture farming company.

TEN Holdings

Market Cap: US$6.4m

Provides event planning, production, and broadcasting services in the United States.

Ensysce Biosciences

Market Cap: US$6.3m

A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

Vision Marine Technologies

Market Cap: US$6.2m

Designs, develops, manufactures, rents, and sells electric boats in Canada, the United States, and internationally.

Globavend Holdings

Market Cap: US$6.1m

Provides integrated cross-border logistics services, and air freight forwarding services in Hong Kong, Australia, and New Zealand.

Flora Growth

Market Cap: US$6.1m

Engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide.

Mainz Biomed

Market Cap: US$5.8m

Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.

HCW Biologics

Market Cap: US$5.7m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

Sonoma Pharmaceuticals

Market Cap: US$5.7m

Develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

Revelation Biosciences

Market Cap: US$5.7m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

Jaguar Health

Market Cap: US$5.5m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

cbdMD

Market Cap: US$5.5m

Produces and distributes various cannabidiol (CBD) products in the United States.

Actelis Networks

Market Cap: US$5.4m

Engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication governmental agencies and companies in North America, Europe, the Middle East, Africa, and the Asia Pacific.

Interactive Strength

Market Cap: US$5.2m

Develops and sells specialty fitness equipment and virtual training for the commercial and at-home markets in the United States, Europe, and Asia.

Xcel Brands

Market Cap: US$4.5m

Operates as a media and consumer products company in the United States.

60 Degrees Pharmaceuticals

Market Cap: US$4.5m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

AIM ImmunoTech

Market Cap: US$4.3m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

CNS Pharmaceuticals

Market Cap: US$4.3m

A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors.

Aclarion

Market Cap: US$4.2m

Operates as a healthcare technology company in the United States.

Urgent.ly

Market Cap: US$4.2m

Operates mobility assistance software platform that matches vehicle owners and operators with service professionals for roadside assistance, proactive maintenance, and repair services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Indaptus Therapeutics

Market Cap: US$3.9m

A clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products.

Algorhythm Holdings

Market Cap: US$3.9m

Engages in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings in North America, Australia, the United Kingdom, Europe, and internationally.

Sadot Group

Market Cap: US$3.9m

Provides supply chain solutions that address growing food security challenges worldwide.

Azitra

Market Cap: US$3.8m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

My Size

Market Cap: US$3.7m

An omnichannel e-commerce platform, provides AI-driven software as a service measurement solution for fashion ecommerce companies in Israel and Spain.

Oragenics

Market Cap: US$3.6m

A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.

TruGolf Holdings

Market Cap: US$3.5m

Through its subsidiary, engages in the design, development, manufacture, and sale of golf simulators for residential and commercial applications in the United States.